About Hull Associates
Hull Associates is a Healthcare company based in Rockland (United States) founded in 2007, and was acquired by Avania in October 2023. Provider of market access and reimbursement consulting services for biopharma sector. Hull Associates offers products and services including Market Access Services, Strategic Consulting, Clinical Operations, Data Analytics, and Imaging Core Lab. Its focus areas include Biopharma Outsourcing, Consulting, Business and Market Access & HEOR. Its competitors include Target RWE, Secura Bio and STATinMED Research; 1 of its 3 listed competitors has raised funding.
Company details
Hull Associates, founded in 2007 in Rockland, United States, focuses on providing healthcare solutions, biopharma outsourcing, offering consulting services, business, and market access heor. Provider of market access and reimbursement consulting services for biopharma sector. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
- Headquarters Rockland, United States
- Stage Acquired
- SectorsHealthcare
- Website hullassociates.com
- Social LinkedIn X
- Acquired by Avania (Oct 2023)
- Investors
- Acquired byAvania
(Oct 2023)
Products & Services of Hull Associates
Hull Associates offers a comprehensive portfolio of products and services, including Market Access Services, Strategic Consulting, Clinical Operations, Data Analytics, and Imaging Core Lab.
Supports global reimbursement strategies for medical devices
Assists with planning and innovation in medical technology
Manages trials and data analytics for MedTech products
Provides safety and compliance solutions for healthcare
Offers imaging support for medical device evaluations
Investors in Hull Associates
Hull Associates has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Avania Clinical.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Regulatory, clinical trials, and analytic services are provided in healthcare. | 1988 | avaniaclinical.com | Brunswick, Australia |
Investor details for Hull Associates
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Hull Associates
2 dated milestones of Hull Associates across 16 years, from founding to its latest funding, stage changes and deals.
- Founded Hull Associates is founded.
- Exit Acquired by Avania.
Competitors of Hull Associates
Hull Associates has 3 listed competitors in our database, 1 of them funded. They include Target RWE, Secura Bio and STATinMED Research.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| targetrwe.com | 2017 | Durham, United States | 116 | Marketing services to the pharmaceutical industry are provided. | ||
| securabio.com | 2018 | Henderson, United States | $55M | Consulting services for market access and health outcomes are provided. | ||
| statinmed.com | 2007 | Ann Arbor, United States | Healthcare data analytics services provider |
Detailed competitors of Hull Associates
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Hull Associates (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Hull Associates
Complete news archive for Hull Associates
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hull Associates
Hull Associates was founded in 2007.
Hull Associates is headquartered in Rockland, United States. It is registered at Rockland, Maine, United States.
Hull Associates, founded in 2007 in Rockland, United States, focuses on providing healthcare solutions, biopharma outsourcing, offering consulting services, business, and market access heor. Provider of market access and reimbursement consulting services for biopharma sector. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
Hull Associates's top competitors include Target RWE, STATinMED Research and Secura Bio.
Hull Associates offers Market Access Services, Strategic Consulting, Clinical Operations, Data Analytics, and Imaging Core Lab.
Hull Associates has 1 investor. Key investors include Avania Clinical.
Yes. Hull Associates was acquired by Avania in October 2023.

